Global X Robotics & Artificial Intelligence ETF
BOTZ - ETF AI Analysis
Top Page
Global X Robotics & Artificial Intelligence ETF (BOTZ)
BOTZ, the Global X Robotics & Artificial Intelligence ETF, earns a solid overall rating driven mainly by strong, financially sound leaders like Intuitive Surgical, Keyence, ABB, and Nvidia, all of which show robust performance and strategic positioning in robotics and AI. However, several key holdings share similar concerns around high valuations and occasional bearish or overbought technical signals, creating risk from both sector concentration in robotics/AI and exposure to potentially overvalued stocks that can add volatility to the fund’s returns.
BOTZ vs. SPDR S&P 500 ETF (SPY)
- AUM
- 2.99B
- Region
- Developed Markets
- Expense Ratio
- 0.68%
- Beta
- 1.49
- Issuer
- Global X
- Inception Date
- Sep 12, 2016
- Dividend Yield
- 0.56%
- Asset Class
- Equity
- Index Tracked
- Indxx Global Robotics & Artificial Intelligence Thematic Index
BOTZ Summary
BOTZ is the Global X Robotics & Artificial Intelligence ETF, which follows the Indxx Global Robotics & Artificial Intelligence Thematic Index. It invests in companies building robots and AI tools used in areas like manufacturing, healthcare, and automation. Well-known holdings include Nvidia and Tesla, along with Intuitive Surgical, a leader in robotic surgery. Someone might invest in BOTZ to tap into the long-term growth potential of robotics and AI while getting global diversification in one fund. A key risk is that it’s heavily focused on technology and automation, so its price can rise and fall sharply with changes in the tech sector and overall market.
How much will it cost me?
BOTZ has an expense ratio of 0.68%, which means you’ll pay about $6.80 per year for every $1,000 invested. This cost is higher than the average ETF because BOTZ is a specialized, actively managed thematic fund focused on robotics and artificial intelligence companies.
What would affect this ETF?
BOTZ could benefit if demand for automation and AI keeps growing across manufacturing, healthcare, and other industries, boosting companies like Nvidia, Intuitive Surgical, and Tesla, especially in stable developed markets. On the downside, higher interest rates, slower global growth, or tighter tech and AI regulations could hurt these industrial and technology names and make this focused robotics and AI ETF more volatile than a broad market fund.
BOTZ Top 10 Holdings
BOTZ is essentially a bet on the global robotics and AI boom, with a heavy tilt toward industrial automation and surgical robots. Intuitive Surgical has been rising lately, helping to pull the fund forward, while Keyence adds steady strength from Japan’s factory automation scene. Nvidia is more of a mixed engine right now—its longer-term AI story is strong, but recent trading has been choppy. ABB and Fanuc have been lagging, acting like a bit of a brake on performance. Overall, BOTZ is a concentrated, developed-markets play on automation rather than a broad tech basket.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 ISRG | Intuitive Surgical | 10.43% | $311.84M | $155.83B | -23.16% | 78Outperform |
 JP:6954 | Fanuc Corporation | 8.48% | $253.70M | JPY 5.24T | 5.95% | 74Outperform |
 KYCCF | Keyence | ― | ― | ― | ― | 81Outperform |
 SE:ABB | ABB Ltd | ― | ― | ― | ― | 78Outperform |
 NVDA | Nvidia | 6.68% | $199.77M | $4.19T | -14.25% | 76Outperform |
 JP:6273 | SMC (OR) | 4.44% | $132.82M | JPY 3.82T | 11.57% | 72Outperform |
 JP:6383 | Daifuku Co | 3.32% | $99.41M | JPY 1.91T | -5.76% | 72Outperform |
 CGNX | Cognex | 2.42% | $72.32M | $8.71B | 32.98% | 70Outperform |
 TSLA | Tesla | 2.36% | $70.65M | $1.54T | -7.70% | 73Outperform |
 HK:1810 | Xiaomi | 1.97% | $59.05M | HKD 769.24B | -31.40% | 71Outperform |
BOTZ Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BOTZ, the sentiment is Negative. The current price of 31.42 is below the 20-day moving average (MA) of 32.59, below the 50-day MA of 34.19, and below the 200-day MA of 36.30, indicating a bearish trend. The MACD of -0.81 indicates Positive momentum. The RSI at 39.39 is Neutral, neither overbought nor oversold. The STOCH value of 45.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BOTZ.
BOTZ Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| BOTZ | $31.42 | $32.00(1.85% Upside) | $2.99B | 0.68% | 58Neutral |
 AIQ | $59.49 | $85.64(43.96% Upside) | $9.55B | 0.68% | 64Neutral |
 PBPH | $31.50 | $33.39(6.00% Upside) | $1.34B | 0.13% | 70Neutral |
 WCBR | $43.33 | $50.86(17.37% Upside) | $214.06M | 0.45% | 64Neutral |
 WISE | $29.48 | $52.53(78.18% Upside) | $21.57M | 0.35% | 58Neutral |
 IVEP | $23.62 | $36.99(56.63% Upside) | $13.77M | 0.75% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| BOTZ | Global X Robotics & Artificial Intelligence ETF | 31.42 | -3.56 | -10.18% | |
| AIQ | Global X Artificial Intelligence & Technology ETF | 59.49 | 9.39 | 18.73% | |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 31.50 | 6.45 | 25.74% | |
| WCBR | WisdomTree Cybersecurity Fund | 43.33 | 12.75 | 41.67% | |
| WISE | Themes Generative Artificial Intelligence ETF | 29.48 | -9.74 | -24.83% | |
| IVEP | Dan IVES Wedbush AI Power & Infrastructure ETF | 23.61 | -2.48 | -9.52% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.